|
ZBTB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.550200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87982999999559E-05 |
| Normal-vs-Stage2 |
7.097400E-03 |
| Normal-vs-Stage3 |
7.304000E-01 |
| Normal-vs-Stage4 |
5.164000E-01 |
| Stage1-vs-Stage2 |
5.537200E-01 |
| Stage1-vs-Stage3 |
4.424200E-03 |
| Stage1-vs-Stage4 |
7.253500E-02 |
| Stage2-vs-Stage3 |
9.144000E-02 |
| Stage2-vs-Stage4 |
1.183770E-01 |
| Stage3-vs-Stage4 |
3.591000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.994300E-04 |
| Normal-vs-AfricanAmerican |
5.878900E-03 |
| Normal-vs-Asian |
8.378100E-02 |
| Caucasian-vs-AfricanAmerican |
7.734400E-01 |
| Caucasian-vs-Asian |
9.398600E-01 |
| AfricanAmerican-vs-Asian |
8.412000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.0018000000015E-05 |
| Normal-vs-Female |
1.361590E-01 |
| Male-vs-Female |
2.871800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.042200E-03 |
| Normal-vs-Extreme_Weight |
2.12039999999414E-05 |
| Normal-vs-Obese |
2.799800E-01 |
| Normal-vs-Extreme_Obese |
7.318100E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.395000E-01 |
| Normal_Weight-vs-Obese |
9.290400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.345400E-01 |
| Extreme_Weight-vs-Obese |
1.087670E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.930200E-01 |
| Obese-vs-Extreme_Obese |
2.263600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.116200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.249900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.8343099999929E-05 |
| Normal-vs-Age(81-100Yrs) |
1.424260E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.553190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.377800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.094000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.402100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.552500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.329800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.431600E-04 |
| Normal-VS-Type2 PRCC |
1.200010E-04 |
| Normal-VS-KIRP CIMP |
9.135200E-03 |
| Normal-VS-Unclassified PRCC |
1.477970E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.954600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.877280E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.673000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.296680E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.075200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.364350E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.72609999813534E-08 |
| Normal-vs-N1 |
4.017600E-02 |
| Normal-vs-N2 |
6.624200E-02 |
| N0-vs-N1 |
1.167720E-04 |
| N0-vs-N2 |
5.684000E-01 |
| N1-vs-N2 |
1.090600E-01 |
|
|
